BCP Broome Capital Corp

Gemoscan Canada, Inc. ("Gemoscan") - (CNSX:GES) is pleased to announce that it
has entered into a non-exclusive advisory services agreement (the "Agreement")
with Borderline Capital Partners Inc. ("BCP") for the provision of financial and
strategic advisory services ("Advisory Services") to the Company's management
and board of directors. The term of the Agreement shall initially be for a
ninety day period effective April 12, 2011, but is subject to renewal upon
mutual agreement.


The Advisory Services to be provided by BCP include but are not limited to: 

Assisting Gemoscan in structuring and entering into agreements for: Financing to
better position Gemoscan for future growth; Sponsorship Financing which includes
the potential for Gemoscan's graduation to a senior public stock exchange and
Distribution Partnerships which contemplates expanding Gemoscan's commercial
activities into territories outside of Canada.


Gemoscan will pay BCP a referral fee, in cash and stock warrants, equal to a
percentage of any Financing and/or Sponsorship Financing that BCP assists
Gemoscan in securing. As well BCP shall be granted an equity participation in
any Distribution Partnership that BCP assists Gemoscan in securing. Any
Financing, Sponsorship Financing or Distribution Partnership entered into by
Gemoscan shall be at its sole discretion. Gemoscan will also pay BCP a monthly
retainer in cash or common stock, which shall be shall be subtracted from any
referral fee paid to BCP.


ABOUT GEMOSCAN

Founded in 2003 Gemoscan owns and markets the Hemocode System, a well-being
assessment and treatment program that uses its own patented technology and
services to detect and provide recommendations for the management of food
intolerance and its often associated lifestyle affecting conditions such as
fibromyalgia, chronic migraines and headaches, weight management, sleeplessness
and others.


Gemoscan trades on the Canadian National Stock Exchange under the ticker GES and
is quoted on the Munich Stock Exchange under the ticker 1GE.


ABOUT BORDERLINE CAPITAL PARTNERS

BCP advises entrepreneurial, mid-market companies that are considering entering
into critical strategic transactions and require the benefit of an experienced
financial advisor to even the playing field and provide them with expertise in
strategy, transaction structuring, and negotiation.


BCP's clients are globally situated and operate in both public and private
capital. BCP advises on a wide range of transactions, including: mergers and
acquisitions; buy-side advisory mandates; management buyouts; strategic
partnerships, joint ventures and alliances; as well as various forms of
divestitures, spin-offs and restructurings.


Borderline Capital Partners maintains a global presence through offices in New
York, Toronto, Paris, Beijing and Moscow.


The CNSX has not reviewed and does not accept responsibility for the adequacy of
this release. 


Forward-Looking Information 

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact, that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Broome Capital Corp (TSXV:BCP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Broome Capital Corp (TSXV:BCP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024